Skip to main content

Table 1

From: Molecular-based allergy diagnostics in the real world: evidence for a cost explosion and an impact vacuum

 

Adults (n=70)

Children (n=53)

Mean age (sd)

31.9 (12.3)

9.2 (4.2)

% cost increase with MA (range)

156 (11-900)

197 (9-600)

MA test results altered management, n(%)

6 (8.6)

7 (13.2)

MA test results provided useful diagnostic support, n(%)

9 (12.8)

2 (3.7)

MA test results had no impact on diagnosis or management, n(%)

55 (78.6)

44 (83)